The Application Notebook
Barbiturates are a class of antidepressants whose abuse and addiction by recreational users has become a widespread problem (www.nlm.nih.gov). In our work we strived to streamline the barbiturate screening process to provide a fast, cost-effective, and reproducible method from start to finish for forensic labs who are involved in high-throughput processing.
Barbiturates are a class of antidepressants whose abuse and addiction by recreational users has become a widespread problem (www.nlm.nih.gov). In our work we strived to streamline the barbiturate screening process to provide a fast, cost-effective, and reproducible method from start to finish for forensic labs who are involved in high-throughput processing.
Table I: Solid phase extraction: Strata-X-Drug N 100 mg/6 mL (part no. 8B-S129-ECH)
Phenobarbital, butalbital, pentobarbital, amobarbital, and secobarbital were spiked into urine samples at 40, 100, and 125% of cutoff level (300 ng/mL). The spiked urine samples were then subjected to a pretreatment followed by SPE on a 100 mg/6 mL Strata™-X-Drug N tube as specified in Table I. After extraction, the barbiturates were analyzed by LC–MS-MS using a Kinetex® 2.6 μm C18 100 × 2.1 mm core-shell HPLC/UHPLC column with the MS operating in APCI negative mode (Figure 1).
Figure 1: LCâMS-MS analysis of barbiturates.
While developing an extraction method for the barbiturate spiked urine samples it was discovered that conditioning the Strata™-X-Drug N SPE sorbent was not necessary as the elimination of this step did not affect recovery. By skipping this step we were able to save both solvent and time which could drastically improve the efficiency of a high throughput lab. The more efficient SPE extraction also provided high recoveries and excellent reproducibility which is noted in Table II.
Table II: Relative recovery, RSD, and linearity of barbiturates
Downstream LC–MS-MS analysis on the Kinetex® core-shell HPLC/UHPLC column also provided significant benefits as we were able to successfully separate pentobarbital and amobarbital, which differ from each other by the placement of a methyl group which has historically made it difficult to resolve the two compounds. It is thought that the separation on the Kinetex column was made possible by the high peak capacity and efficiency of the Kinetex core-shell particle. Core-shell particles contain a 1.9 μm solid core surrounded by a 0.35 μm porous layer of silica. This allows the particle to perform like a sub-2 μm column in terms of resolution, efficiency, and speed without the limiting backpressures that are associated with sub-2 μm particles making it easy to adopt this technology without having to invest in a UHPLC system.
By pairing a streamlined SPE extraction with an efficient LC–MS-MS analysis, it is possible for any forensic lab to improve their barbiturate screening. Strata-X-Drug N SPE sorbent provided both time and solvent savings which are multiplied when screening numerous samples at once, making it faster and more profitable for forensic labs to screen barbiturate samples. After cleanup, a sensitive LC–MS-MS method on Kinetex 2.6 μm C18 core-shell HPLC/UHPLC columns provides separation and resolution of five barbiturates.
Phenomenex, Inc.
411Madrid Avenue, Torrance, CA 90501
tel. (310) 212-0555, fax (310) 328-7768
Website: www.phenomenex.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.